Alibaba Health Information Technology Limited (ALI HEALTH, 00241.HK) disclosed that on 13 March 2026 it granted 3.88 million restricted share units (RSUs) to 20 employees under its 2024 Share Award Scheme.

• Grant details – Total RSUs: 3,881,600 units, each convertible into one ordinary share upon vesting. – Purchase price: Nil. – Closing price on grant date: HK$5.02 per share.

• Vesting schedule – RSUs vest in tranches over four years from the grant date. – Certain portions may vest within the first 12 months, in line with provisions allowing evenly distributed vesting periods of 12 months or more.

• Performance and clawback provisions – No performance targets are attached to the awards. – Unvested RSUs lapse automatically upon events such as termination for cause, ethical breaches, fraud, or conduct damaging to the group’s reputation.

• Remaining scheme capacity – 1.55 billion shares remain available for future grants under the overall mandate of the 2024 Share Award Scheme. – 160.92 million shares remain available under the scheme’s service-provider sub-limit.

The company stated that the awards aim to attract and retain talent, acknowledge employee contributions, and support future expansion goals. None of the grantees are directors, chief executives, substantial shareholders, related-entity participants, or service providers, and no financial assistance was provided for share purchases.